The Doping Control Committee (DCC) oversees doping control policy and procedures for Physique Canada. The DCC also metes out sanctions against athletes who fail doping control.

Standing Committee

Chair:                        Michael James
Secretary:                  Brian Robitaille, C-DCO, PCP
Member:                    Martin Tessier, S-DCO
Member:                    Debbie Laurin-Leclerc, Chief Judge
Member:                    Doug Schneider, VP
Athlete member:         vacant
Athlete member:         vacant

Committee Charter

The DCC shall meet as required from time to time to discuss policy and procedures. The committee shall be consulted by the C-DCO for results management purposes. Sanctions meted out by the DCC against doping control infractions shall be considered on a case-by-base basis, according to the policies. The committee shall perform an internal audit annually, vaildating all doping control measures conducted in the past year.

Contact

Contact the committee by email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Men's and Women's Competition Levels

  • Prize $$
  • Tier 1
  • Pro
  • Competitors must qualify by placing top three in a Tier 2 event and must maintain a valid membership for year-round in- and out-of-competition drug testing.

  • More
  • Tier 2
  • Open
  • Competitors must have placed top three in Tier 3 or have strong competitive experience and/or have placed in another organization. All Tier 2 competitions subject to drug testing.
  • More
  • Tier 3
  • Novice
  • For brand-new competitors or those who have not placed in Physique Canada Tier 3 or in another organization. All Tier 3 competitions subject to drug testing.

  • More
  • Masters
  • Over Age 40
  • Resides outside the tier system. Competitors can compete in Masters even if they are competing in Tier 1, 2, or 3 classes. All Masters competitions subject to drug testing.
  • More

About

Physique Canada is the only men's and women's physique organization in the nation to conduct in-competition and out-of-competition drug testing, with the express purpose of creating a fair and level playing field for all competitors.